Fred Crawford to Cost-Benefit Analysis
This is a "connection" page, showing publications Fred Crawford has written about Cost-Benefit Analysis.
Connection Strength
0.020
-
Administration of recombinant activated factor VII in the intensive care unit after complex cardiovascular surgery: clinical and economic outcomes. J Thorac Cardiovasc Surg. 2011 Jun; 141(6):1469-77.e2.
Score: 0.020